Fig. 3From: Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancerHigher CA-125 decreasing kinetics (a, b) is associated with longer OS and PFS in patients with advanced HG-SOCs who underwent NAC/IDSBack to article page